Companies /Consumer Defensive

Altria Group Inc

NYSE: MO Tobacco
$68.88
▼ $0.61 (−0.88%) today
Markets closed · 4:49pm ET

Q2 2025 Earnings

Reported Jul 30, 2025, 7:03am ET · SEC source
$1.44
Beat +3.99%
EPS · est. $1.38
$5.3B
Beat +1.94%
Revenue · est. $5.2B
+7.6%
Beating market
MO vs S&P since report
1 quarter
Consecutive EPS beats

Market Reaction

% change · around the report
0+2%+4%Jul 30Jul 31report 7:03am ETearnings+0.2%+4.2%
0+2%+4%Jul 30Jul 31earnings+0.2%+4.2%
MO +4.2%S&P 500 +0.2%
0+2%+4%Jul 30Jul 31report 7:03am ETearnings+0.2%+4.2%
0+2%+4%Jul 30Jul 31earnings+0.2%+4.2%
MO +4.2%NASDAQ +0.2%
−3%0+3%+6%Jul 29Aug 7report 7:03am ETearnings+0.0%+5.7%
−3%0+3%+6%Jul 29Aug 7earnings+0.0%+5.7%
MO +5.7%S&P 500 +0.0%
−3%0+3%+6%Jul 29Aug 7report 7:03am ETearnings+0.5%+5.7%
−3%0+3%+6%Jul 29Aug 7earnings+0.5%+5.7%
MO +5.7%NASDAQ +0.5%
+3.61%
Day of report
+0.72%
Next session
+2.68%
One week
+9.28%
30 days

S&P 500 over the same 30 days: +1.67%.

Did MO Beat Earnings? Q2 2025 Results

Altria Group delivered a solid beat on both top and bottom lines in the second quarter of 2025, with <a href="https://247wallst.com/investing/2025/07/30/live-dividend-giant-altria-nyse-mo-releases-earnings-today/">adjusted earnings coming in</a> at $1.44 per share, clearing the $1.3848 consensus estimate by 3.99%, while revenues net of excise taxes reached $5.29 billion against expectations of $5.19 billion — a 1.94% beat and a modest 0.3% gain year-over-year. The headline driver was disciplined pricing power in the smokeable products segment, where adjusted operating margins expanded 2.9 percentage points to 64.5% despite a 10.2% decline in domestic cigarette shipment volumes — a drop management attributed largely to illicit flavored disposable e-vapor products flooding the market. Oral tobacco added another growth layer, with on! nicotine pouch volumes climbing 26.5% to 52.1 million cans. The strong first-half performance prompted Altria to narrow its full-year 2025 adjusted EPS guidance to $5.35–$5.45, raising the lower end to reflect 3.0%–5.0% growth, even as management cautioned that second-half comparisons will be tougher. Altria's stock has climbed roughly 17.6% year-to-date, reflecting renewed investor confidence in the company's pricing resilience.

Key Takeaways
  • Higher pricing in smokeable and oral tobacco segments
  • Lower per unit settlement charges in smokeable products
  • on! nicotine pouch shipment volume growth of 26.5%
  • Fewer shares outstanding due to share repurchase program
  • Adjusted OCI margin expansion in both smokeable (64.5%) and oral tobacco (68.7%) segments
  • Lower costs across segments

“In the second quarter, we continued the pursuit of our Vision while maintaining our strong and profitable core businesses. In oral tobacco, on! delivered strong performance and was the substantial driver of the segment's growth in the quarter. And we returned significant value to our loyal shareholders during the first-half of the year, with more than $4 billion delivered through dividends and share repurchases.”

Altria CEO, on the earnings call

Forward Guidance & Outlook

Altria narrowed its 2025 full-year adjusted diluted EPS guidance to $5.35–$5.45, raising the lower end, representing 3.0%–5.0% growth from a 2024 base of $5.19. Management expects EPS growth to moderate in the second half as the company laps the lower share count from the 2024 accelerated share repurchase program and the MSA legal fund expiration benefit in Q4. Guidance contemplates the estimated impact of increased tariffs on costs, assumes limited volume impact from illicit product enforcement, and assumes NJOY ACE does not return to the marketplace this year. The company expects a 2025 adjusted effective tax rate of 23%–24%, capital expenditures of $175–$225 million, and depreciation and amortization of approximately $290 million. The guidance includes planned investments in smoke-free product marketplace activities and R&D, as well as reinvestment of anticipated cost savings from the Optimize & Accelerate initiative.

MO YoY Financials

Q2 2025 vs Q2 2024 · SEC filings Q2 2024 Q2 2025
$0$2.0B$4.0B$5.3B$5.3BRevenue$3.7B$3.9BGross Profit$2.5B$3.2BOperating Income$3.8B$2.4BNet Income
$0$2.0B$4.0BRevenueGross ProfitOperating IncomeNet Income

MO Revenue by Segment

Smokeable Products$5.4B−2.5%
Oral Tobacco Products$753.0M+5.9%
E-Vapor Products

Figures from SEC filings and company reports. Not investment advice.